Association between levodopa administration and melanoma: A systematic review

Fernanda Luparelli Mello and Marcelo Adrian Estrin

SCT Proceedings in Interdisciplinary Insights and Innovations, 2024, vol. 2, 10.56294/piii2024355

Abstract: Introduction: Parkinson's disease (PD) is a neurodegenerative disease and levodopa is the main drug used in the treatment of this disease. A study conducted in Denmark demonstrated a two-fold higher incidence of malignant melanoma in patients with Parkinson's, but no correlation was found between levodopa treatment and this incidence. The present systematic review used search engines such as pubmed and Google academic to search for articles of the clinical and randomized trial type. The results of the systematic review indicate a complexity in the relationship between levodopa administration, Parkinson's disease, and melanoma risk. The evidence reviewed suggests that levodopa does not appear to be a significant causal factor in the development of melanoma in patients with Parkinson's disease. Despite the problems raised, the well-established therapeutic benefits of levodopa in the management of the symptoms of Parkinson's disease continue to outweigh the potential risk of causing melanoma. The study concludes that there is an increased risk of developing melanoma in patients with Parkinson's disease but that there is no evidence of a causal role of levodopa in increasing this risk or accelerating its growth

Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:procee:v:2:y:2024:i::p:1056294piii2024355:id:1056294piii2024355

Access Statistics for this article

More articles in SCT Proceedings in Interdisciplinary Insights and Innovations from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().